MX2019007352A - Composiciones de aminoacidos y metodos para el tratamiento de enfermedades y transtornos musculares. - Google Patents
Composiciones de aminoacidos y metodos para el tratamiento de enfermedades y transtornos musculares.Info
- Publication number
- MX2019007352A MX2019007352A MX2019007352A MX2019007352A MX2019007352A MX 2019007352 A MX2019007352 A MX 2019007352A MX 2019007352 A MX2019007352 A MX 2019007352A MX 2019007352 A MX2019007352 A MX 2019007352A MX 2019007352 A MX2019007352 A MX 2019007352A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acid
- methods
- disorders
- treatment
- acid compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 208000029578 Muscle disease Diseases 0.000 title 2
- 208000021642 Muscular disease Diseases 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000004220 muscle function Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente descripción proporciona composiciones que comprender entidades de aminoácidos. La descripción también proporciona métodos para mejorar función muscular que comprende la administración de una cantidad eficaz de las proporciones a un sujeto que lo necesita.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662436073P | 2016-12-19 | 2016-12-19 | |
US201762443205P | 2017-01-06 | 2017-01-06 | |
US201762491776P | 2017-04-28 | 2017-04-28 | |
US201762545358P | 2017-08-14 | 2017-08-14 | |
US201762576321P | 2017-10-24 | 2017-10-24 | |
PCT/US2017/067368 WO2018118957A1 (en) | 2016-12-19 | 2017-12-19 | Amino acid compositions and methods for the treatment of muscle diseases and disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019007352A true MX2019007352A (es) | 2019-09-05 |
Family
ID=61025047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019007352A MX2019007352A (es) | 2016-12-19 | 2017-12-19 | Composiciones de aminoacidos y metodos para el tratamiento de enfermedades y transtornos musculares. |
Country Status (21)
Country | Link |
---|---|
US (3) | US20180207119A1 (es) |
EP (1) | EP3554493A1 (es) |
JP (1) | JP2020502183A (es) |
KR (1) | KR20190099243A (es) |
CN (1) | CN110267655A (es) |
AU (1) | AU2017379825A1 (es) |
BR (1) | BR112019012476A2 (es) |
CA (1) | CA3046558A1 (es) |
CL (1) | CL2019001685A1 (es) |
CO (1) | CO2019006292A2 (es) |
CU (1) | CU20190057A7 (es) |
EC (1) | ECSP19043725A (es) |
IL (1) | IL267210A (es) |
JO (1) | JOP20190147A1 (es) |
MA (1) | MA50763A (es) |
MX (1) | MX2019007352A (es) |
PE (1) | PE20191206A1 (es) |
PH (1) | PH12019501339A1 (es) |
TW (1) | TWI780096B (es) |
WO (1) | WO2018118957A1 (es) |
ZA (1) | ZA201903581B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN110678172A (zh) | 2017-04-28 | 2020-01-10 | 胺细拉健康公司 | 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法 |
CA3072092A1 (en) * | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | Branched-chain amino acids for the treatment of neuronal injury |
CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
US11679089B2 (en) | 2018-06-20 | 2023-06-20 | Axcella Health Inc. | Methods of manufacturing amino acid compositions |
JP2021527670A (ja) | 2018-06-20 | 2021-10-14 | アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. | 筋肉中の脂肪浸潤の治療のための組成物及び方法 |
CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
KR102456270B1 (ko) * | 2019-09-24 | 2022-10-19 | 마이오텍사이언스 주식회사 | 비천연 아미노산 유도체를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
KR102338447B1 (ko) * | 2019-09-24 | 2021-12-14 | 마이오텍사이언스 주식회사 | 비천연 아미노산을 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
US20230089723A1 (en) * | 2020-03-06 | 2023-03-23 | Axcella Health Inc. | Amino acid compositions and methods for muscle and myotube modulation |
CN113288890B (zh) * | 2021-06-21 | 2022-02-22 | 南方医科大学南方医院 | N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用 |
WO2024026307A1 (en) | 2022-07-25 | 2024-02-01 | Axcella Health Inc. | Biomarker for long covid and fatigue |
WO2024030909A1 (en) | 2022-08-01 | 2024-02-08 | Axcella Health Inc. | Biomarkers of amino acid composition treatment response in long covid |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020090214A (ko) * | 2000-02-01 | 2002-11-30 | 머슬테크 리서치 앤드 디벨롭먼트, 인크. | 근육을 키우거나 강도를 늘리기 위한 α리포산계의보조식품 |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US20060002913A1 (en) * | 2004-06-22 | 2006-01-05 | Gehlsen Kurt R | Use of histamine and related compounds to treat disorders affecting muscle function |
EP1865944B1 (en) * | 2005-03-29 | 2018-08-29 | Ajinomoto Co., Inc. | Amino acid-containing composition used for preventing or remedying decrease in skeletal muscle mass of aged people, comprising L-leucine |
JP2007023921A (ja) * | 2005-07-19 | 2007-02-01 | Toyota Motor Corp | 内燃機関の制御装置 |
US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
CN100518815C (zh) * | 2007-02-15 | 2009-07-29 | 北京苏里曼医药科技有限公司 | 一种氨基酸组合物 |
CA2845829A1 (en) * | 2011-08-19 | 2013-02-28 | Musclepharm Corporation | Compositions and methods for use in promoting lean body mass |
WO2015061607A1 (en) * | 2013-10-23 | 2015-04-30 | Whitehead Institute For Biomedical Research | Mtorc1 modulation by amino acids and uses thereof |
-
2017
- 2017-06-16 JO JOP/2019/0147A patent/JOP20190147A1/ar unknown
- 2017-12-19 MA MA050763A patent/MA50763A/fr unknown
- 2017-12-19 KR KR1020197020658A patent/KR20190099243A/ko not_active Application Discontinuation
- 2017-12-19 PE PE2019001282A patent/PE20191206A1/es unknown
- 2017-12-19 WO PCT/US2017/067368 patent/WO2018118957A1/en unknown
- 2017-12-19 CU CU2019000057A patent/CU20190057A7/es unknown
- 2017-12-19 BR BR112019012476A patent/BR112019012476A2/pt active Search and Examination
- 2017-12-19 TW TW106144666A patent/TWI780096B/zh active
- 2017-12-19 MX MX2019007352A patent/MX2019007352A/es unknown
- 2017-12-19 US US15/847,343 patent/US20180207119A1/en not_active Abandoned
- 2017-12-19 JP JP2019532941A patent/JP2020502183A/ja active Pending
- 2017-12-19 CN CN201780078594.XA patent/CN110267655A/zh active Pending
- 2017-12-19 EP EP17835529.3A patent/EP3554493A1/en active Pending
- 2017-12-19 CA CA3046558A patent/CA3046558A1/en active Pending
- 2017-12-19 AU AU2017379825A patent/AU2017379825A1/en not_active Abandoned
- 2017-12-29 US US15/858,605 patent/US20180169047A1/en not_active Abandoned
- 2017-12-29 US US15/858,475 patent/US20180169046A1/en not_active Abandoned
-
2019
- 2019-06-04 ZA ZA2019/03581A patent/ZA201903581B/en unknown
- 2019-06-10 IL IL267210A patent/IL267210A/en unknown
- 2019-06-13 PH PH12019501339A patent/PH12019501339A1/en unknown
- 2019-06-17 CO CONC2019/0006292A patent/CO2019006292A2/es unknown
- 2019-06-19 CL CL2019001685A patent/CL2019001685A1/es unknown
- 2019-06-19 EC ECSENADI201943725A patent/ECSP19043725A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JOP20190147A1 (ar) | 2019-06-18 |
US20180169047A1 (en) | 2018-06-21 |
CN110267655A (zh) | 2019-09-20 |
CU20190057A7 (es) | 2020-02-04 |
US20180169046A1 (en) | 2018-06-21 |
MA50763A (fr) | 2019-10-23 |
PE20191206A1 (es) | 2019-09-10 |
ECSP19043725A (es) | 2019-07-31 |
ZA201903581B (en) | 2020-12-23 |
AU2017379825A1 (en) | 2019-06-13 |
WO2018118957A1 (en) | 2018-06-28 |
PH12019501339A1 (en) | 2019-09-30 |
TWI780096B (zh) | 2022-10-11 |
BR112019012476A2 (pt) | 2020-04-14 |
KR20190099243A (ko) | 2019-08-26 |
EP3554493A1 (en) | 2019-10-23 |
JP2020502183A (ja) | 2020-01-23 |
IL267210A (en) | 2019-08-29 |
US20180207119A1 (en) | 2018-07-26 |
CA3046558A1 (en) | 2018-06-28 |
CL2019001685A1 (es) | 2019-08-30 |
CO2019006292A2 (es) | 2019-06-28 |
TW201827068A (zh) | 2018-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019501339A1 (en) | Amino acid compositions and methods for the treatment of muscle diseases and disorders | |
PH12019501414A1 (en) | Amino acid compositions and methods for the treatment of liver diseases | |
PH12017500746B1 (en) | Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease | |
ZA202001057B (en) | Inhibiting ubiquitin specific peptidase 30 | |
JOP20200033A1 (ar) | تركيبات حمض أميني لمعالجة مرض كبدي | |
MX2017001279A (es) | Usos y composiciones de la flagelina. | |
MX2019000965A (es) | Composiciones y metodos para inihibir la masp-3 para el tratamiento de diferentes enfermedades y trastornos. | |
EA201992607A1 (ru) | Твердые формы берберина урсодезоксихолата, их композиции и способы | |
MX2018006247A (es) | Metodos para tratar la enfermedad de alzheimer y trastornos relacionados. | |
PH12018501443A1 (en) | Methods of administering hepcidin | |
MD20160007A2 (ro) | Inhibitori ai RORC2 şi metode de utilizare a acestora | |
EA201691567A1 (ru) | Способы лечения легких травм головного мозга | |
PH12018502161A1 (en) | Methods of treatment for cholestatic and fibrotic diseases | |
MX2019001634A (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos. | |
MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
MX2020001428A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
PH12019501358A1 (en) | Methods of administering hepcidin | |
NZ724799A (en) | Compositions and methods for the treatment or prevention of neurodegenerative disorders | |
GEP20207145B (en) | Combination of trazodone and gabapentin for the treatmen | |
PH12017501693A1 (en) | Compositions for the treatment of kidney and/or liver diseases | |
TW201613926A (en) | Inhibitors of bruton's tyrosine kinase | |
EA201991504A1 (ru) | Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц | |
MX2017014893A (es) | Composicion herbal para el tratamiento del dolor de espalda. | |
IN2013MU03429A (es) |